The role of presenilins in Alzheimer's disease.

In the past few years, 2 homologous polytopic membrane proteins termed presenilins (PSs) have been the focus of several research groups interested in the molecular mechanisms of Alzheimer’s disease (AD). Mutations in the Presenilin 1 (PS1) and Presenilin 2 (PS2) genes account for the majority of the cases of familial earlyonset AD (see the Perspective by Tanzi in the previous issue of the JCI). Analysis of PS1 null mice and other model systems reveals a role for PS1 in development. Furthermore, biochemical and genetic evidence indicate that PS1 plays an important role in facilitating the proteolytic processing of certain proteins, including amyloid precursor protein (APP) and Notch1. Mutant PS proteins influence the γ-secretase‐mediated processing of APP, cause a selective increase in the levels of highly fibrillogenic Aβ42 species, and accelerate Aβ deposition in the brains of transgenic mice. This apparent gain of function of mutant PS in AD seems to be distinct from the role of PS1 in development. Although PS1 interacts with several proteins, including members of the armadillo family of proteins, thus far none of the PS-interacting proteins have been shown to play a direct role in the enhanced production of Aβ42 mediated by mutant PS. This review focuses on the unusual and fascinating aspects of PS metabolism, its role in facilitating the trafficking and cleavage of a set of membrane-bound proteins, and its role in the pathogenesis of AD. The genetics and structure of the presenilins. Approximately 10% of all cases of Alzheimer’s disease (AD) are estimated to be early-onset familial AD (FAD) and show autosomal dominant inheritance. Mutations in the Presenilin 1 (PS1) gene and the related gene Presenilin 2 (PS2), located on chromosomes 14 and 1, respectively, are causative in approximately 50% of pedigrees with FAD. Since 1995, more than 50 different mutations in PS1 have been described in over 80 families of various ethnic origins with early-onset FAD. With 2 notable exceptions (one, a deletion of 30 amino acids, and the other, insertion of 1 amino acid), mutations in presenilins are missense substitutions that result in single amino acid changes. In contrast to PS1 mutations, thus far only 2 mutations in PS2 have been described. These alleles occur in families with variable onset, autosomal dominant FAD. PS1 is a 467‐amino acid polypeptide predicted to contain between 7 and 9 transmembrane-spanning domains and to include a hydrophilic “loop” region. A variety of biochemical and cell biologic approaches were used to determine the topology of PS1 and the Caenorhabditis elegans homologues SEL12 and HOP-1. These data generally predict that the NH2-terminus, the

[1]  M. Frosch,et al.  Presenilin 1 Facilitates the Constitutive Turnover of β-Catenin: Differential Activity of Alzheimer’s Disease–Linked PS1 Mutants in the β-Catenin–Signaling Pathway , 1999, The Journal of Neuroscience.

[2]  E. Mandelkow,et al.  Proteolysis by presenilins and the renaissance of tau. , 1999, Trends in cell biology.

[3]  C. L. Harris,et al.  Evidence That Intramolecular Associations between Presenilin Domains Are Obligatory for Endoproteolytic Processing* , 1999, The Journal of Biological Chemistry.

[4]  T. Golde,et al.  γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying Length* , 1999, The Journal of Biological Chemistry.

[5]  Iva Greenwald,et al.  Presenilin is required for activity and nuclear access of Notch in Drosophila , 1999, Nature.

[6]  M. Fortini,et al.  Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants , 1999, Nature.

[7]  K. Duff,et al.  Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes , 1999, The Journal of Neuroscience.

[8]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[9]  D. Linden,et al.  Synaptic Transmission and Hippocampal Long-Term Potentiation in Transgenic Mice Expressing FAD-Linked Presenilin 1 , 1999, Neurobiology of Disease.

[10]  R. Rozmahel,et al.  Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complex , 1999, Nature Medicine.

[11]  D. Borchelt,et al.  Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons , 1998, Neuron.

[12]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[13]  I. Greenwald,et al.  Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans. , 1998, Development.

[14]  T. Iwatsubo,et al.  Mutant Presenilin 2 Transgenic Mouse: Effect on an Age‐Dependent Increase of Amyloid β‐Protein 42 in the Brain , 1998, Journal of neurochemistry.

[15]  T. Tabira,et al.  Both N‐terminal and C‐terminal fragments of Presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease , 1998, Journal of neuroscience research.

[16]  D. Selkoe,et al.  The Proteolytic Fragments of the Alzheimer’s Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex* , 1998, The Journal of Biological Chemistry.

[17]  C. L. Harris,et al.  Stable Association of Presenilin Derivatives and Absence of Presenilin Interactions with APP , 1998, Neurobiology of Disease.

[18]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[19]  M. Mattson,et al.  Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease , 1998, Journal of neurochemistry.

[20]  R. Sherrington,et al.  Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain Tissue , 1997, Neurobiology of Disease.

[21]  C. L. Harris,et al.  Evidence That Levels of Presenilins (PS1 and PS2) Are Coordinately Regulated by Competition for Limiting Cellular Factors* , 1997, The Journal of Biological Chemistry.

[22]  D. Selkoe,et al.  Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Tanzi,et al.  Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. , 1997, Science.

[24]  R. Tanzi,et al.  Endoproteolytic Cleavage and Proteasomal Degradation of Presenilin 2 in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[25]  T. Iwatsubo,et al.  The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Beyreuther,et al.  Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein , 1997, Nature Medicine.

[27]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.

[28]  J. Hardy,et al.  Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.

[29]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[30]  D. Borchelt,et al.  Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.

[31]  P. Vito,et al.  Interfering with Apoptosis: Ca2+-Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3 , 1996, Science.

[32]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[33]  J. Hardy,et al.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. , 1996, Nature medicine.